GOLDSTEIN DOV A MD

CIK 000112047810 companiesEMERYVILLE, CA

SEC Profile

Transactions

Companies

Filings

CIK

0001120478

Recent Transactions

50 trades

Exercise/Conversion
BioAge Labs, Inc.$BIOA
Common Stock
2026-01-16$4.38/sh+3,542→ 25,950 total
Exercise/Conversion
BioAge Labs, Inc.$BIOA
Stock Option (Right to Buy)
2026-01-16−3,542→ 166,458 total
Sale
BioAge Labs, Inc.$BIOA
Common Stock
2026-01-13$21.08/sh−1,923→ 22,408 total
Sale
BioAge Labs, Inc.$BIOA
Common Stock
2026-01-13$19.45/sh−4,440→ 35,994 total
Sale
BioAge Labs, Inc.$BIOA
Common Stock
2026-01-13$18.43/sh−8,974→ 40,434 total
Exercise/Conversion
BioAge Labs, Inc.$BIOA
Stock Option (Right to Buy)
2026-01-13−27,000→ 92,587 total
Exercise/Conversion
BioAge Labs, Inc.$BIOA
Common Stock
2026-01-13$8.39/sh+27,000→ 49,408 total
Sale
BioAge Labs, Inc.$BIOA
Common Stock
2026-01-13$20.54/sh−11,663→ 24,331 total
Award
Coya Therapeutics, Inc.$COYA
Stock Option (right to buy)
2026-01-02+10,000→ 10,000 total
Exercise/Conversion
Coya Therapeutics, Inc.$COYA
Common Stock, par value $0.0001 per share
2025-08-18$1.09/sh+17,557→ 27,557 total
Exercise/Conversion
Coya Therapeutics, Inc.$COYA
Stock Option (right to buy)
2025-08-18−17,557→ 0 total
Award
Gain Therapeutics, Inc.$GANX
Stock Option (right to buy)
2025-06-24+15,000→ 15,000 total
Award
Coya Therapeutics, Inc.$COYA
Stock Option (right to buy)
2025-02-25+5,000→ 5,000 total
Award
BioAge Labs, Inc.$BIOA
Stock Option (Right to Buy)
2025-02-18+170,000→ 170,000 total
Award
Coya Therapeutics, Inc.$COYA
Stock Option (right to buy)
2025-01-01+5,000→ 5,000 total
Award
Gain Therapeutics, Inc.$GANX
Stock Option (right to buy)
2024-06-24+15,000→ 15,000 total
Award
Coya Therapeutics, Inc.$COYA
Stock Option (right to buy)
2024-01-01+5,000→ 5,000 total
Award
Gain Therapeutics, Inc.$GANX
Stock Option (right to buy)
2023-06-23+10,500→ 10,500 total
Purchase
Coya Therapeutics, Inc.$COYA
Common Stock, par value $0.0001 per share
2023-01-03+10,000→ 10,000 total
Purchase
Coya Therapeutics, Inc.$COYA
Warrant to Purchase Common Stock
2023-01-03+5,000→ 5,000 total
Award
Gain Therapeutics, Inc.$GANX
Stock Option (right to buy)
2022-09-20+10,500→ 10,500 total
Award
NeuBase Therapeutics, Inc.
Stock option (right to buy)
2022-09-09+37,600→ 37,600 total
Award
NeuBase Therapeutics, Inc.
Stock option (right to buy)
2021-08-19+38,135→ 38,135 total
Purchase
NeuBase Therapeutics, Inc.
Common Stock
2021-06-18$4.75/sh+8,000→ 30,000 total
Purchase
NeuBase Therapeutics, Inc.
Common Stock
2021-04-26$5.00/sh+12,000→ 22,000 total
Award
NeuBase Therapeutics, Inc.
Stock option (right to buy)
2020-09-09+14,634→ 14,634 total
Purchase
NeuBase Therapeutics, Inc.
Common Stock
2020-04-30$6.00/sh+10,000→ 10,000 total
Award
ADMA BIOLOGICS, INC.$ADMA
Common Stock
2020-02-28+7,500→ 7,500 total
Award
ADMA BIOLOGICS, INC.$ADMA
Employee Stock Option (right to buy)
2020-02-28+15,000→ 15,000 total
Award
ADMA BIOLOGICS, INC.$ADMA
Common Stock
2020-02-28+7,500→ 7,500 total
Award
NeuBase Therapeutics, Inc.
Stock option (right to buy)
2019-07-12+227,330→ 227,330 total
Award
ADMA BIOLOGICS, INC.$ADMA
Stock Option (right to buy)
2019-03-13+30,000→ 30,000 total
Award
ADMA BIOLOGICS, INC.$ADMA
Stock Option (right to buy)
2018-06-22+17,500→ 17,500 total
Exercise/Conversion
Esperion Therapeutics, Inc.$ESPR
Stock Option (right to buy)
2018-06-06+8,000→ 0 total
Exercise/Conversion
Esperion Therapeutics, Inc.$ESPR
Stock Option (right to buy)
2018-06-06+5,000→ 0 total
Other
Esperion Therapeutics, Inc.$ESPR
Common Stock
2018-06-06−8,000→ 47 total
Exercise/Conversion
Esperion Therapeutics, Inc.$ESPR
Common Stock
2018-06-06$17.75/sh+8,000→ 13,047 total
Exercise/Conversion
Esperion Therapeutics, Inc.$ESPR
Common Stock
2018-06-06$14.42/sh+5,000→ 5,047 total
Other
Esperion Therapeutics, Inc.$ESPR
Common Stock
2018-06-06−5,000→ 8,047 total
Award
Esperion Therapeutics, Inc.$ESPR
Stock Option (right to buy)
2018-05-23+10,100→ 10,100 total
Other
Esperion Therapeutics, Inc.$ESPR
Common Stock
2017-12-18−21,471→ 47 total
Exercise/Conversion
Esperion Therapeutics, Inc.$ESPR
Common Stock
2017-12-18$3.70/sh+21,471→ 21,518 total
Exercise/Conversion
Esperion Therapeutics, Inc.$ESPR
Stock Option (right to buy)
2017-12-18−21,471→ 0 total
Other
Esperion Therapeutics, Inc.$ESPR
Common Stock
2017-12-05+38→ 47 total
Award
ADMA BIOLOGICS, INC.$ADMA
Stock Option (right to buy)
2017-06-06+53,837→ 53,837 total
Award
Esperion Therapeutics, Inc.$ESPR
Stock Option (right to buy)
2017-04-17+14,000→ 14,000 total
Sale
Esperion Therapeutics, Inc.$ESPR
Common Stock
2017-03-22$38.82/sh−312,642→ 837,125 total
Sale
Esperion Therapeutics, Inc.$ESPR
Common Stock
2017-03-21$43.48/sh−487,358→ 1,149,767 total
Sale
MELINTA THERAPEUTICS, INC. /NEW/
Common Stock
2017-03-08$3.57/sh−99,900→ 0 total
Sale
MELINTA THERAPEUTICS, INC. /NEW/
Common Stock
2017-03-07$3.53/sh−50,100→ 99,900 total

Companies

Recent Filings

Address

C/O BIOAGE LABS, INC. 5885 HOLLIS STREET, SUITE 370

EMERYVILLE, CA, 94608

View on SEC.gov